144 related articles for article (PubMed ID: 17562865)
1. Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway.
Chauvin C; Salhi S; Jean-Jean O
Mol Cell Biol; 2007 Aug; 27(16):5619-29. PubMed ID: 17562865
[TBL] [Abstract][Full Text] [Related]
2. Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.
Chauvin C; Salhi S; Le Goff C; Viranaicken W; Diop D; Jean-Jean O
Mol Cell Biol; 2005 Jul; 25(14):5801-11. PubMed ID: 15987998
[TBL] [Abstract][Full Text] [Related]
3. [Influence of individual domains of the translation termination factor eRF1 on induction of the GTPase activity of the translation termination factor eRF3].
Dubovaia VI; Kolosov PM; Alkalaeva EZ; Frolova LIu; Kiselev LL
Mol Biol (Mosk); 2006; 40(2):310-6. PubMed ID: 16637272
[TBL] [Abstract][Full Text] [Related]
4. Role of the individual domains of translation termination factor eRF1 in GTP binding to eRF3.
Kononenko AV; Mitkevich VA; Dubovaya VI; Kolosov PM; Makarov AA; Kisselev LL
Proteins; 2008 Feb; 70(2):388-93. PubMed ID: 17680691
[TBL] [Abstract][Full Text] [Related]
5. [Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo].
Jakobsen CG; Segaard TM; Jean-Jean O; Frolova L; Justesen J
Mol Biol (Mosk); 2001; 35(4):672-81. PubMed ID: 11524954
[TBL] [Abstract][Full Text] [Related]
6. In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3.
Alkalaeva EZ; Pisarev AV; Frolova LY; Kisselev LL; Pestova TV
Cell; 2006 Jun; 125(6):1125-36. PubMed ID: 16777602
[TBL] [Abstract][Full Text] [Related]
7. Evolution of translation termination factor eRF3: is GSPT2 generated by retrotransposition of GSPT1's mRNA?
Zhouravleva G; Schepachev V; Petrova A; Tarasov O; Inge-Vechtomov S
IUBMB Life; 2006 Apr; 58(4):199-202. PubMed ID: 16754297
[TBL] [Abstract][Full Text] [Related]
8. [Conservation of the MC domains in eukaryotic termination factor eRF3].
Zhuravleva GA; Zemlianko OM; Le Goff C; Petrova AV; Philippe M; Inge-Vechtomov SG
Genetika; 2007 Jan; 43(1):38-44. PubMed ID: 17333937
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against human translation termination factor eRF3 and their utilization for sub-cellular localization of eRF3.
Delage MM; Dutertre S; Le Guével R; Frolova L; Berkova N
J Biochem; 2011 Jul; 150(1):49-59. PubMed ID: 21421683
[TBL] [Abstract][Full Text] [Related]
10. The role of N-terminal domain of translational release factor eRF3 for the control of functionality and stability in S. cerevisiae.
Kodama H; Ito K; Nakamura Y
Genes Cells; 2007 May; 12(5):639-50. PubMed ID: 17535254
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal degradation of human release factor eRF3a regulates translation termination complex formation.
Chauvin C; Jean-Jean O
RNA; 2008 Feb; 14(2):240-5. PubMed ID: 18083835
[TBL] [Abstract][Full Text] [Related]
12. Termination of translation in eukaryotes is mediated by the quaternary eRF1*eRF3*GTP*Mg2+ complex. The biological roles of eRF3 and prokaryotic RF3 are profoundly distinct.
Mitkevich VA; Kononenko AV; Petrushanko IY; Yanvarev DV; Makarov AA; Kisselev LL
Nucleic Acids Res; 2006; 34(14):3947-54. PubMed ID: 16914449
[TBL] [Abstract][Full Text] [Related]
13. Class-1 release factor eRF1 promotes GTP binding by class-2 release factor eRF3.
Hauryliuk V; Zavialov A; Kisselev L; Ehrenberg M
Biochimie; 2006 Jul; 88(7):747-57. PubMed ID: 16797113
[TBL] [Abstract][Full Text] [Related]
14. Studies on human eRF3-PABP interaction reveal the influence of eRF3a N-terminal glycin repeat on eRF3-PABP binding affinity and the lower affinity of eRF3a 12-GGC allele involved in cancer susceptibility.
Jerbi S; Jolles B; Bouceba T; Jean-Jean O
RNA Biol; 2016; 13(3):306-15. PubMed ID: 26818177
[TBL] [Abstract][Full Text] [Related]
15. C-terminal 76 amino acids of eRF3 are not required for the binding of release factor eRF1a from Euplotes octocarinatus.
Song L; Wang Y; Chai B; Wang W; Liang A
J Genet Genomics; 2007 Jun; 34(6):486-90. PubMed ID: 17601607
[TBL] [Abstract][Full Text] [Related]
16. Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway.
Hoshino S; Hosoda N; Araki Y; Kobayashi T; Uchida N; Funakoshi Y; Katada T
Biochemistry (Mosc); 1999 Dec; 64(12):1367-72. PubMed ID: 10648960
[TBL] [Abstract][Full Text] [Related]
17. PABP enhances release factor recruitment and stop codon recognition during translation termination.
Ivanov A; Mikhailova T; Eliseev B; Yeramala L; Sokolova E; Susorov D; Shuvalov A; Schaffitzel C; Alkalaeva E
Nucleic Acids Res; 2016 Sep; 44(16):7766-76. PubMed ID: 27418677
[TBL] [Abstract][Full Text] [Related]
18. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways.
Chiang PC; Lin SC; Pan SL; Kuo CH; Tsai IL; Kuo MT; Wen WC; Chen P; Guh JH
Biochem Pharmacol; 2010 Jan; 79(2):162-71. PubMed ID: 19723512
[TBL] [Abstract][Full Text] [Related]
19. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation.
Valouev IA; Kushnirov VV; Ter-Avanesyan MD
Cell Motil Cytoskeleton; 2002 Jul; 52(3):161-73. PubMed ID: 12112144
[TBL] [Abstract][Full Text] [Related]
20. Expression, characterization and immunolocalization of translation termination factor eRF3 in the ciliate Euplotes octocarinatus.
Chai BF; Wang W; Liang AH
Res Microbiol; 2006 Apr; 157(3):235-40. PubMed ID: 16229990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
